Condition
Dry Eyes Chronic
Total Trials
6
Recruiting
0
Active
0
Completed
1
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 5/100
Termination Rate
0.0%
0 terminated out of 6 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
50%
3 trials in Phase 3/4
Results Transparency
100%
1 of 1 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
6Total
Not Applicable (1)
Early P 1 (1)
P 1 (1)
P 3 (1)
P 4 (2)
Trial Status
Not Yet Recruiting3
Withdrawn2
Completed1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 1 completed trials
Clinical Trials (6)
Showing 6 of 6 trials
NCT07267481Phase 4Not Yet Recruiting
Switching From Xiidra to TRYPTYR
NCT06903611Phase 3Not Yet Recruiting
Phase III Study of Topical Fibrinogen-Depleted Human Platelet Lysate Compared to Placebo for Moderate to Severe Dry Eye
NCT06379685Phase 1Not Yet Recruiting
Study to Evaluate the Safety and Tolerability of PRO-190 Ophthalmic Solution Compared to Systane Ultra® on the Ocular Surface.
NCT05169931Early Phase 1WithdrawnPrimary
Clinical Efficacy of Amniotic Membrane Extract Eye Drops in Dry Eye Treatment
NCT03952481Phase 4Withdrawn
Effect of Lifitegrast 5% on Tear Film Markers
NCT03089580Not ApplicableCompletedPrimary
Intense Pulsed Light Study for Dry Eye Disease
Showing all 6 trials